# Nell Meosky Luo

> Nell Meosky Luo is the founder and CEO of Folia Health, based in Cambridge, Massachusetts. A Yale graduate and former Oliver Wyman consultant, she connected with technical cofounder Dan Toffling through an online ad and has written extensively about data ownership, transparency, and recognizing contributors. Folia announced a $10.5 million Series A in October 2025.

- **Role:** Founder and CEO at Folia Health
- **Organizations:** Folia Health, Oliver Wyman, Yale University, Rock Health
- **Education:** Bachelor’s degree in History of Science & Medicine and Public Health; cum laude, with Distinction in the major, Yale University, Attended before transferring to Yale; no degree established, Massachusetts Institute of Technology
- **Known for:** Graduated from Yale cum laude and with Distinction in her major., Founded and leads Folia Health alongside technical cofounder Dan Toffling., Rock Health Innovation Fellow in 2022.

## Career timeline

- **Before 2016** — Worked as a management consultant at Oliver Wyman across several industries.
- **2016** — Founded Folia Health.
- **2019** — Appeared with cofounder Dan Toffling on Angel Invest Boston; published essays on data ownership and the development of Data Dividends.
- **2022** — Named a Rock Health Innovation Fellow, as recorded in her Worth biography.
- **2025** — Folia announced a $10.5 million Series A on October 1; Nell joined a company-building panel at Fierce Biotech Week on October 8.
- **2026** — Published a January 5 reflection on the early feedback and relationships behind Folia.

## Achievements

- Graduated from Yale cum laude and with Distinction in her major.
- Founded and leads Folia Health alongside technical cofounder Dan Toffling.
- Rock Health Innovation Fellow in 2022.
- Led Folia through its announced $10.5 million Series A in October 2025.

## Latest updates

- **2026-01** — Published “To this fresh year and the best of people,” reflecting on Folia’s earliest user feedback and collaborators.
- **2025-10** — Participated in an October 8 Fierce Biotech Week panel with Brad Flint, Annie Mitsak, and Tom Neyarapally.
- **2025-10** — Folia announced a $10.5 million Series A led by S3 Ventures, with Crosslink Capital and Create Health Ventures.
- **2025-09** — Revisited her 2019 writing in a September 30 essay about AI and data quality.

## Links

- Website: https://www.foliahealth.com
- LinkedIn: https://www.linkedin.com/in/nell-meosky-luo

---

Profile page: https://yespress.io/nell-meosky-luo
Published by YesPress — https://yespress.io
Last updated: 2026-10-25